Low testosterone (male hypogonadism)
Treatment of low testosterone
Some causes, such as obesity, can be reversible without testosterone therapy, and the Endocrine Society says these should be addressed first [1]. For men with consistently low testosterone and symptoms of deficiency, clinician-prescribed testosterone replacement therapy can be effective, and raising levels can improve sexual concerns, bone health, muscle and anemia [1]. It comes as injections, gels, patches, tablets placed on the gums, pellets under the skin and a nasal gel, each with its own side effects [1].
Who should not use it. The Endocrine Society says testosterone therapy is not for men with known or suspected prostate or breast cancer, an enlarged prostate causing trouble urinating, a raised PSA, a high red blood cell count, untreated sleep apnea, a heart attack or stroke in the last 6 months, blood clots, or plans to have children [1].
Possible risks. These include lower sperm production, a high red blood cell count, acne, prostate enlargement and, rarely, sleep apnea [1]. In 2025 the FDA reported that testosterone products raise blood pressure and required a warning about it [3]. The same review found that the TRAVERSE trial showed no increase in the risk of adverse cardiovascular outcomes in men using testosterone for hypogonadism [3]. The FDA kept a limitation of use for age-related low testosterone [3].
Not every cause can be prevented. The Endocrine Society lists obesity, type 2 diabetes and sleep disorders among the conditions linked to low testosterone, and says some causes, such as obesity, can be reversible [1]. Read about overweight and obesity and sleep apnea.
Sources
- 1. Hypogonadism in Men (opens external site) — Endocrine Society, Diagnosis; Symptoms; Causes; Treatment and therapies; Treatment risks · Accessed Sep 24, 2026
- 2. Testosterone Levels Test (opens external site) — MedlinePlus (National Library of Medicine), What is it used for?; What happens during the test?; What do the results mean? · Accessed Sep 24, 2026
- 3. FDA issues class-wide labeling changes for testosterone products (opens external site) — U.S. Food and Drug Administration, 2/28/2025 labeling changes (TRAVERSE trial; blood pressure) · Accessed Sep 24, 2026
- 4. Hypogonadism (opens external site) — MedlinePlus (National Library of Medicine), Causes; Symptoms; Exams and tests · Accessed Sep 24, 2026